BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25106798)

  • 1. MicroRNA regulates vascular endothelial growth factor expression in chondrosarcoma cells.
    Sun X; Wei L; Chen Q; Terek RM
    Clin Orthop Relat Res; 2015 Mar; 473(3):907-13. PubMed ID: 25106798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis.
    Sun X; Charbonneau C; Wei L; Chen Q; Terek RM
    Mol Cancer Res; 2015 Sep; 13(9):1347-57. PubMed ID: 26013170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia induces HIF-1alpha and VEGF expression in chondrosarcoma cells and chondrocytes.
    Lin C; McGough R; Aswad B; Block JA; Terek R
    J Orthop Res; 2004 Nov; 22(6):1175-81. PubMed ID: 15475194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WISP-3 inhibition of miR-452 promotes VEGF-A expression in chondrosarcoma cells and induces endothelial progenitor cells angiogenesis.
    Lin CY; Tzeng HE; Li TM; Chen HT; Lee Y; Yang YC; Wang SW; Yang WH; Tang CH
    Oncotarget; 2017 Jun; 8(24):39571-39581. PubMed ID: 28465477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells.
    Liu GT; Huang YL; Tzeng HE; Tsai CH; Wang SW; Tang CH
    Cancer Lett; 2015 Feb; 357(2):476-87. PubMed ID: 25444917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphiregulin enhances VEGF-A production in human chondrosarcoma cells and promotes angiogenesis by inhibiting miR-206 via FAK/c-Src/PKCδ pathway.
    Wang CQ; Huang YW; Wang SW; Huang YL; Tsai CH; Zhao YM; Huang BF; Xu GH; Fong YC; Tang CH
    Cancer Lett; 2017 Jan; 385():261-270. PubMed ID: 27826039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 promotes vascular endothelial growth factor-dependent angiogenesis in human chondrosarcoma cells.
    Wu MH; Huang CY; Lin JA; Wang SW; Peng CY; Cheng HC; Tang CH
    Oncogene; 2014 Mar; 33(13):1725-35. PubMed ID: 23584483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL5 promotes VEGF-dependent angiogenesis by down-regulating miR-200b through PI3K/Akt signaling pathway in human chondrosarcoma cells.
    Liu GT; Chen HT; Tsou HK; Tan TW; Fong YC; Chen PC; Yang WH; Wang SW; Chen JC; Tang CH
    Oncotarget; 2014 Nov; 5(21):10718-31. PubMed ID: 25301739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in cartilage tumors.
    Kouvaras E; Christoni Z; Siasios I; Malizos K; Koukoulis GK; Ioannou M
    Biotech Histochem; 2019 May; 94(4):283-289. PubMed ID: 30605014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-miRNA Oligonucleotide Therapy for Chondrosarcoma.
    Sun X; Chen Y; Yu H; Machan JT; Alladin A; Ramirez J; Taliano R; Hart J; Chen Q; Terek RM
    Mol Cancer Ther; 2019 Nov; 18(11):2021-2029. PubMed ID: 31341031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathway.
    Sun W; Wang X; Li J; You C; Lu P; Feng H; Kong Y; Zhang H; Liu Y; Jiao R; Chen X; Ba Y
    Cell Death Dis; 2018 Apr; 9(4):438. PubMed ID: 29739921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
    Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
    Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTS1 is regulated by interleukin-1beta, not by hypoxia, in chondrosarcoma.
    Kalinski T; Krueger S; Sel S; Werner K; Röpke M; Roessner A
    Hum Pathol; 2007 Jan; 38(1):86-94. PubMed ID: 16949904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis.
    Tzeng HE; Chen PC; Lin KW; Lin CY; Tsai CH; Han SM; Teng CL; Hwang WL; Wang SW; Tang CH
    Clin Sci (Lond); 2015 Jul; 129(2):147-58. PubMed ID: 25735814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistin facilitates VEGF-A-dependent angiogenesis by inhibiting miR-16-5p in human chondrosarcoma cells.
    Chen SS; Tang CH; Chie MJ; Tsai CH; Fong YC; Lu YC; Chen WC; Lai CT; Wei CY; Tai HC; Chou WY; Wang SW
    Cell Death Dis; 2019 Jan; 10(1):31. PubMed ID: 30631040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived neurotrophic factor promotes VEGF-C-dependent lymphangiogenesis by suppressing miR-624-3p in human chondrosarcoma cells.
    Lin CY; Wang SW; Chen YL; Chou WY; Lin TY; Chen WC; Yang CY; Liu SC; Hsieh CC; Fong YC; Wang PC; Tang CH
    Cell Death Dis; 2017 Aug; 8(8):e2964. PubMed ID: 28771226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-148a inhibits early relapsed colorectal cancers and the secretion of VEGF by indirectly targeting HIF-1α under non-hypoxia/hypoxia conditions.
    Tsai HL; Miao ZF; Chen YT; Huang CW; Yeh YS; Yang IP; Wang JY
    J Cell Mol Med; 2019 May; 23(5):3572-3582. PubMed ID: 30834693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin promotes VEGF-A-dependent angiogenesis in human chondrosarcoma through PI3K, Akt, mTOR, and HIF-α pathway.
    Lee HP; Lin CY; Shih JS; Fong YC; Wang SW; Li TM; Tang CH
    Oncotarget; 2015 Nov; 6(34):36746-61. PubMed ID: 26468982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visfatin Facilitates VEGF-D-Induced Lymphangiogenesis through Activating HIF-1α and Suppressing miR-2277-3p in Human Chondrosarcoma.
    Song CY; Hsieh SL; Yang SY; Lin CY; Wang SW; Tsai CH; Lo YS; Fong YC; Tang CH
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic fibroblast growth factor promotes VEGF-C-dependent lymphangiogenesis via inhibition of miR-381 in human chondrosarcoma cells.
    Tzeng HE; Chang AC; Tsai CH; Wang SW; Tang CH
    Oncotarget; 2016 Jun; 7(25):38566-38578. PubMed ID: 27229532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.